Asthma: BREYNA is used to control symptoms of asthma, and prevent symptoms such as wheezing in adults and children ages 6 and older. BREYNA contains formoterol. LABA medicines such as formoterol when used alone increase the risk of death and hospitalizations from asthma problems. BREYNA contains an ICS and a LABA. When an ICS and a LABA are used together, there is not a significant increased risk in hospitalizations and death from asthma problems. BREYNA is not for adults and children with asthma who are well controlled with an asthma-control medicine, such as a low-to-medium dose of an ICS. BREYNA is for adults and children with asthma who need both an ICS and a LABA medicine. It is not known if BREYNA is safe and effective in children less than 6 years of age with asthma.